Ganglioside GM3 (d18:1/22:0)

(2S,3R,4E)-2-(Docosanoylamino)-3-hydroxy-4-octadecen-1-yl 5-acetamido-3,5-dideoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-threo-hex-2-ulopyranonosyl-(2->3)-β-D-galactopyranosyl-(1->4)-β-D-mann opyranoside

(2S,3R,4E)-2-(Docosanoylamino)-3-hydroxy-4-octadecen-1-yl-5-acetamido-3,5-didesoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-threo-hex-2-ulopyranonosyl-(2->3)-β-D-galactopyranosyl-(1->4)-β-D-man nopyranosid

5-Acétamido-3,5-didésoxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-β-L-thréo-hex-2-ulopyranonosyl-(2->3)-β-D-galactopyranosyl-(1->4)-β-D-mannopyranoside de (2S,3R,4E)-2-(docosanoylamino)-3-hydroxy-4 -octadécén-1-yle

54827-14-4

Docosanamide, N-[(1S,2R,3E)-1-[[[O(6ξ)-5-(acetylamino)-3,5-dideoxy-α-D-gluco-2-nonulopyranonosyl-(2->3)-O-β-D-galactopyranosyl-(1->4)-β-D-mannopyranosyl]oxy]methyl]-2-hydroxy-3-heptadecen-1 -yl]-

Ganglioside GM3 (d18:1/22:0)

(2S,4S,5R)-2-{[(2S,3R,4S,5S,6R)-2-{[(2R,3S,4R,6R)-6-{[(2S,3R,4E)-2-docosanamido-3-hydroxyoctadec-4-en-1-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-5-acetamido-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypr

(N-Acetylneuraminyl)-D-galactosyl-D-glucosylceramide

(N-Acetylneuraminyl)-δ-galactosyl-δ-glucosylceramide

Ganglioside GM3

Ganglioside M3

Hematoside

N-Acetylneuraminyl-2,3-α-D-galactosyl-1,4-β-D-glucosylceramide

N-Acetylneuraminyl-2,3-α-δ-galactosyl-1,4-β-δ-glucosylceramide

Neu5Ac-α2->3Gal-β1->4Glc-β1->1′Cer

Sialosyllactosylceramide

α-N-Acetylneuraminyl-2,3-β-D-galactosyl-1,4-β-D-glucosylceramide

α-N-Acetylneuraminyl-2,3-β-δ-galactosyl-1,4-β-δ-glucosylceramide